The Food and Drug Administration (FDA) has reached a deal with Abbott Laboratories that will allow the company to begin producing baby formula once again …
The Food and Drug Administration (FDA) has reached a deal with Abbott Laboratories that will allow the company to begin producing baby formula once again at its Sturgis, Michigan plant. The agency helped Abbott initiate a voluntary recall and shutdown of new production of its formula in February after the Michigan factory was linked to several bacterial outbreaks in infants in the last year. The company said Monday that the consent decree should lead to production ramping back up within a couple of weeks of the FDA approving its reopening, and more formula would be on shelves six to eight weeks thereafter.
